These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26694825)

  • 41. Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports.
    Arai J; Shimozuma Y; Otoyama Y; Sugiura I; Nakajima Y; Hayashi E; Kajiwara A; Omori R; Uozumi S; Miyashita M; Uchikoshi M; Doi H; Sakaki M; Wang T; Eguchi J; Ito T; Kurihara T; Munechika J; Gokan T; Saito K; Miura S; Tate G; Takimoto M; Yoshida H
    BMC Gastroenterol; 2019 Nov; 19(1):187. PubMed ID: 31727083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrast-enhanced ultrasonography for characterization of canine focal liver lesions.
    Nakamura K; Takagi S; Sasaki N; Bandula Kumara WR; Murakami M; Ohta H; Yamasaki M; Takiguchi M
    Vet Radiol Ultrasound; 2010; 51(1):79-85. PubMed ID: 20166400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deep learning approach for discrimination of liver lesions using nine time-phase images of contrast-enhanced ultrasound.
    Kamiyama N; Sugimoto K; Nakahara R; Kakegawa T; Itoi T
    J Med Ultrason (2001); 2024 Jan; 51(1):83-93. PubMed ID: 38051461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison Between Low Mechanical Index and High Mechanical Index Contrast Modes of Contrast-Enhanced Ultrasonography: Evaluation of Perfusion Defects of Hypervascular Hepatocellular Carcinomas During the Post-Vascular Phase.
    Duisyenbi Z; Numata K; Nihonmatsu H; Fukuda H; Chuma M; Kondo M; Nozaki A; Tanaka K; Maeda S
    J Ultrasound Med; 2019 Sep; 38(9):2329-2338. PubMed ID: 30653696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation.
    Hiraoka A; Hiasa Y; Onji M; Michitaka K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):616-8. PubMed ID: 21418298
    [No Abstract]   [Full Text] [Related]  

  • 46. Ultrasound imaging of liver metastases in the delayed parenchymal phase following administration of Sonazoid using a destructive mode technique (Agent Detection Imaging).
    Edey AJ; Ryan SM; Beese RC; Gordon P; Sidhu PS
    Clin Radiol; 2008 Oct; 63(10):1112-20. PubMed ID: 18774358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of irreversible electroporation ablation zone using Kupffer-phase contrast-enhanced ultrasound images with Sonazoid.
    Sugimoto K; Moriyasu F; Yoshiyuki K; Imai Y
    J Med Ultrason (2001); 2014 Oct; 41(4):531-2. PubMed ID: 27278039
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of local tumor residue after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma.
    Hamanaka J; Goto T; Nishigori S; Seki S; Ida T; Morohashi T; Ohara H; Inamori M; Maeda S
    Turk J Gastroenterol; 2017 May; 28(3):197-201. PubMed ID: 28294951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US.
    Hatanaka K; Minami Y; Kudo M; Inoue T; Chung H; Haji S
    J Clin Ultrasound; 2014 Jan; 42(1):1-8. PubMed ID: 24738129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Letter to the editor re: contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100).
    Frauscher F
    Eur Radiol; 2011 Nov; 21(11):2311-2; author reply 2313-4. PubMed ID: 21698464
    [No Abstract]   [Full Text] [Related]  

  • 51. [Evaluation of Sorafenib for Hepatocellular Carcinoma with Low α-Fetoprotein by Arrival Time Parametric Imaging Using Contrast-Enhanced Ultrasonography with Sonazoid].
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Shinohara M; Kikuchi Y; Shinohara M; Igarashi Y; Sumino Y
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):215-8. PubMed ID: 27067685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic imaging of hepatocellular carcinoma: recent progress.
    Kudo M
    Oncology; 2011; 81 Suppl 1():73-85. PubMed ID: 22212940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index.
    Luo W; Numata K; Kondo M; Morimoto M; Sugimori K; Hirasawa K; Nozaki A; Zhou X; Tanaka K
    J Ultrasound Med; 2009 Apr; 28(4):439-48. PubMed ID: 19321671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
    Xia Y; Kudo M; Minami Y; Hatanaka K; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Kitai S; Takahashi S; Tatsumi C; Ueda T; Hayaishi S; Maekawa K
    Oncology; 2008; 75 Suppl 1():99-105. PubMed ID: 19092278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.
    Jiang HY; Chen J; Xia CC; Cao LK; Duan T; Song B
    World J Gastroenterol; 2018 Jun; 24(22):2348-2362. PubMed ID: 29904242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.
    Numata K; Morimoto M; Ogura T; Sugimori K; Takebayashi S; Okada M; Tanaka K
    J Ultrasound Med; 2008 Mar; 27(3):395-406. PubMed ID: 18314518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma.
    Kudo M; Hatanaka K; Kumada T; Toyoda H; Tada T
    Am J Gastroenterol; 2011 Feb; 106(2):368-70. PubMed ID: 21301463
    [No Abstract]   [Full Text] [Related]  

  • 59. Contrast enhanced ultrasound of hepatocellular carcinoma.
    Numata K; Luo W; Morimoto M; Kondo M; Kunishi Y; Sasaki T; Nozaki A; Tanaka K
    World J Radiol; 2010 Feb; 2(2):68-82. PubMed ID: 21160920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamic Contrast-Enhanced Ultrasonography with Sonazoid for Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma.
    Li X; Han X; Li L; Su C; Sun J; Zhan C; Feng D; Cheng W
    Ultrasound Med Biol; 2022 Mar; 48(3):575-581. PubMed ID: 34933756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.